share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 21 07:33
Summary by Futu AI
AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.